Cascadian Therapeutics | Evaluate

January 31, 2018

Seattle disappoints Puma bulls with Cascadian takeout

Minor delay puts neratinib on collision course with Aphinity

June 03, 2015

Asco Event Analyzer – 2015’s winners and losers

June 02, 2015

Asco – Puma might have to rely on extended follow-up

June 01, 2015

Asco – Oncothyreon puts on better form with breast cancer project

August 20, 2014

Oncothyreon’s promise grows distant

September 25, 2013

Merck pushes on with failed cancer vaccine

June 06, 2013

Asco Event Analyzer – 2013’s winners and losers

February 01, 2013

EP Vantage Interview – Immatics ponders cash call as data approaches

January 09, 2013

Sarepta joins the big league as best-performing 2012 share

December 19, 2012

Stimuvax doomed in lung cancer

Load More